SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John H. Farro who wrote (3899)9/18/1998 12:25:00 PM
From: Elllk   of 4342
 
Robin

Interesting article. There have may a few attacks in the media, current one after NE J of Medicine study attacking alternative and supplement/herbal treatments. In addition to the issue of intended biological activity of supplements the NE J Med points out problems of harmful fillers and additives adding toxicity to herbal, etc, tablets. Since PRLN has the technology to determine toxicity of many things this should also be something examined in the BioFit analysis. And this is exactly what the supplement field needs, at this point, for quality in both of these respects to be certified. Especially since it does appear, from recent escalation of attacks, that the AMA, etc., is making a concerted effort against supplements/alternative treatments, etc.

Larry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News